Related Experiment Video
Updated: Jun 24, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Neuroscience basis of clinical depression: implications for future antidepressant drug development
Sheldon H Preskorn1, Wayne C Drevets
1Department of Psychiatry, University of Kansas School of Medicine-Wichita, KS, USA.
Abstract:
This column reviews progress in our understanding of the neuroanatomy, pathophysiology, and genetics underlying clinical depression. Such understanding is fundamental to the ability to rationally identify the neural regulatory processes involved and develop drugs specifically targeted to those processes. The goal of the column is to help clinicians better conceptualize the nature of depressive illness and its treatment and educate their patients about these issues.
Related Concept Videos
Depression: Overview
Antidepressant Drugs: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
G-protein Coupled Receptors

